If you or a loved one were prescribed and took Uloric (febuxostat) and suffered a cardiovascular event or stroke, you may be entitled to compensation for your injuries. Contact the Kishish Law Group today for your free and confidential case evaluation by calling us toll free at 1 (888) 609-4664 or completing our contact form.
Uloric (febuxostat) is a drug commonly prescribed for treatment of gout. The U.S. Food and Drug Administration issued a warning in Feburary 2019 saying that the FDA had determined that patients who took Uloric instead of a comparable gout drug had a higher risk of death from cardiovascular events.
Injured patients and their families are now filing lawsuits against Takeda Pharmaceuticals, the manufacturer of Uloric. People who took Uloric and experienced heart problems or stroke may be able to recover medical bills and other costs associated with treating problems that Uloric may have caused. Filing a lawsuit can also send a strong signal to pharmaceutical companies that they should make sure that their drugs are safe before they bring them to market.
What is Uloric?
Uloric is a drug that is often prescribed to treat chronic gout. Gout is a type of arthritis that results from a build up of uric acid in the blood. High levels of uric acid can cause the formation of urate crystals, which then build up in joints and lead to inflammation, redness, intense joint pain, and a limited range of motion. Uloric works by blocking the formation of an enzyme in the body that creates uric acid. Doctors may prescribe Uloric instead of allopurinol, another gout drug that is cheaper and equally effective.
What are the potential dangers of Uloric?
Studies have shown that taking Uloric can cause an increased risk of death from cardiovascular events. The original applications to the FDA to have Uloric approved in 2005 and 2006 were denied because the FDA was concerned that clinical trials had shown a risk of cardiovascular events.
The FDA ultimately approved Uloric in 2009 on the condition that Takeda Pharmaceuticals conduct a safety study. In a study funded by Takeda Pharmaceuticals, researchers compared the effects of allopurinol and Uloric in over 6,000 patients. The research, published in the New England Journal of Medicine, found that death from all causes and death from cardiovascular events were higher in patients that took Uloric. The FDA reported on the preliminary results from this study in 2017 and then in 2019 required the manufacturer to place a "boxed warning" on Uloric.
What are the symptoms of the adverse effects of Uloric?
According to the FDA's warning, patients taking Uloric should contact a medical professional if they experience the following symptoms:
- Chest pain
- Shortness of breath
- Rapid or irregular heartbeat
- Numbness or weakness on one side of your body
- Trouble talking
- Sudden severe headache
The FDA cautions that patients should not stop taking Uloric without consulting a medical professional.
What does the Uloric lawsuit say?
Most Uloric lawsuits say that the manufacturer failed to warn the drug's users of its dangerous side effects. Lawsuits will claim that Takeda Pharmaceuticals should have warned potential users of the increased risk of death.
Has there been a recall of Uloric?
Uloric has not been formally recalled yet by the FDA. In 2018, Public Citizen filed a petition with the FDA to have Uloric removed from the market, which the FDA denied. The FDA does now require a "boxed warning" on Uloric, but has not moved to remove it from the market.
Do I have a Uloric lawsuit?
Contacting a lawyer is the best way to determine whether you have a Uloric lawsuit. Everyone's case will be different and an experienced legal practitioner is in the best position to help you decide your legal path forward. The Kishish Law Group's lawyers and staff will listen to your story and explain your options. Our consultations are free and confidential. If you think you may have a Uloric lawsuit, contact us today by calling us toll free at 1 (888) 609-4664 or by completing our contact form.
DISCLAIMER: No attorney client relationship will exist between you and our firm until we enter into a signed Retainer/Services Agreement. Completion of this document is for informational purposes only and does not constitute a Retainer/Services Agreement. The information you obtain at this site is not, nor is it intended to be, legal advice. Contacting us does not create an attorney-client relationship. In some jurisdictions this website may be considered lawyer advertising. You should consult an attorney for advice regarding your individual situation. Click here for more information.
Speak with an Uloric Lawyer
If you were prescribed and took Uloric (febuxostat) and suffered a cardiovascular event or stroke, you may be entitled to compensation for your injuries.
Reach out to Kishish Law Group immediately to find out your legal options.
- April 1, 2020
FDA Requests Companies to Stop Selling All Zantac Products, Citing Cancer Concerns
- August 13, 2018
FDA Updates List of Valsartan Blood Pressure Medication Affected by Recall
- February 18, 2018
Invokana Lawsuits Rise, First Trial of Alleged Amputation Set for September
- June 12, 2017
Invokana Side Effects and Diabetic Ketoacidosis
- June 8, 2017
SGLT2 Inhibitors, like Invokana, Found to Double Risk of Diabetic Ketoacidosis